A detailed history of Davies Financial Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Davies Financial Advisors, Inc. holds 3,483 shares of ABBV stock, worth $611,545. This represents 0.6% of its overall portfolio holdings.

Number of Shares
3,483
Previous 4,179 16.65%
Holding current value
$611,545
Previous $717 Million 4.03%
% of portfolio
0.6%
Previous 0.67%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$163.84 - $199.33 $114,032 - $138,733
-696 Reduced 16.65%
3,483 $688 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $35,137 - $41,032
-227 Reduced 5.15%
4,179 $717 Million
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $704,166 - $802,332
4,406 New
4,406 $802 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Davies Financial Advisors, Inc. Portfolio

Follow Davies Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davies Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Davies Financial Advisors, Inc. with notifications on news.